$7.24 Billion is the total value of Bellevue Group AG's 261 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 21.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INCY | Sell | INCYTE CORP | $294,298,000 | -14.0% | 3,279,450 | -0.4% | 4.07% | -16.1% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $261,398,000 | -8.4% | 960,600 | -2.2% | 3.61% | -10.5% |
| MRNA | Sell | MODERNA INC | $236,443,000 | +10.1% | 3,341,950 | -0.1% | 3.27% | +7.5% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $227,108,000 | -4.8% | 1,559,805 | -3.1% | 3.14% | -7.0% |
| MYOK | Sell | MYOKARDIA INC | $153,835,000 | +31.8% | 1,128,400 | -6.6% | 2.13% | +28.7% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $143,729,000 | -20.3% | 5,469,131 | -18.7% | 1.99% | -22.2% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $108,690,000 | +22.1% | 153,184 | -2.0% | 1.50% | +19.2% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $91,861,000 | -5.3% | 3,579,919 | -5.3% | 1.27% | -7.6% |
| MDT | Sell | MEDTRONIC PLC | $86,404,000 | -3.6% | 831,450 | -14.9% | 1.19% | -5.9% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $79,502,000 | +24.6% | 351,083 | -4.0% | 1.10% | +21.6% |
| SYK | Sell | STRYKER CORPORATION | $67,256,000 | +15.2% | 322,771 | -0.4% | 0.93% | +12.5% |
| CNC | Sell | CENTENE CORP DEL | $60,293,000 | -9.0% | 1,033,647 | -0.9% | 0.83% | -11.2% |
| CI | Sell | CIGNA CORP NEW | $56,877,000 | -10.0% | 335,737 | -0.3% | 0.79% | -12.1% |
| CDNA | Sell | CAREDX INC | $42,337,000 | +2.4% | 1,115,903 | -4.4% | 0.58% | 0.0% |
| EVH | Sell | EVOLENT HEALTH INCcl a | $40,622,000 | +13.5% | 3,273,325 | -34.9% | 0.56% | +10.7% |
| BIO | Sell | BIO RAD LABS INCcl a | $40,302,000 | +11.8% | 78,186 | -2.1% | 0.56% | +9.2% |
| INSM | Sell | INSMED INC | $39,216,000 | -2.2% | 1,220,169 | -16.2% | 0.54% | -4.6% |
| PACB | Sell | PACIFIC BIOSIENCES CALIF IN | $38,537,000 | +33.6% | 3,904,467 | -53.3% | 0.53% | +30.4% |
| BAX | Sell | BAXTER INTL INC | $38,169,000 | -29.1% | 474,623 | -24.1% | 0.53% | -30.8% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $30,732,000 | +13.2% | 225,740 | -0.8% | 0.42% | +10.7% |
| LVGO | Sell | LIVONGO HEALTH INC | $28,476,000 | +47.2% | 203,329 | -21.0% | 0.39% | +43.4% |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $27,706,000 | +2.1% | 84,635 | -14.4% | 0.38% | -0.3% |
| TDOC | Sell | TELADOC HEALTH INC | $26,606,000 | -7.9% | 121,354 | -19.8% | 0.37% | -10.0% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $21,553,000 | +99.7% | 90,518 | -2.8% | 0.30% | +94.8% |
| ILMN | Sell | ILLUMINA INC | $18,096,000 | -49.1% | 58,547 | -39.0% | 0.25% | -50.3% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $17,946,000 | -18.1% | 1,263,811 | -15.1% | 0.25% | -20.0% |
| NEO | Sell | NEOGENOMICS INC | $15,748,000 | +4.7% | 426,892 | -12.1% | 0.22% | +2.3% |
| ZLAB | Sell | ZAI LAB LTDadr | $13,407,000 | -6.8% | 161,200 | -7.9% | 0.18% | -9.3% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $11,286,000 | +3.3% | 39,400 | -32.1% | 0.16% | +0.6% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $11,196,000 | -22.3% | 20,000 | -13.4% | 0.16% | -24.0% |
| CVS | Sell | CVS HEALTH CORP | $10,920,000 | -27.5% | 186,981 | -19.3% | 0.15% | -29.1% |
| SGEN | Sell | SEATTLE GENETICS INC | $9,119,000 | -2.3% | 46,600 | -15.1% | 0.13% | -4.5% |
| GILD | Sell | GILEAD SCIENCES INC | $7,817,000 | -24.5% | 123,700 | -8.0% | 0.11% | -26.0% |
| XENT | Sell | INTERSECT ENT INC | $7,721,000 | +1.3% | 473,382 | -15.9% | 0.11% | -0.9% |
| AVTR | Sell | AVANTOR INC | $6,906,000 | +11.3% | 307,089 | -15.8% | 0.10% | +8.0% |
| AKCA | Sell | AKCEA THERAPEUTICS INC | $6,172,000 | -69.2% | 340,264 | -76.7% | 0.08% | -70.1% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $6,012,000 | -31.6% | 77,400 | -51.1% | 0.08% | -33.1% |
| VCRA | Sell | VOCERA COMMUNICATONS INC | $5,856,000 | -19.7% | 201,390 | -41.5% | 0.08% | -21.4% |
| IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $5,781,000 | -38.8% | 122,426 | -39.1% | 0.08% | -40.3% |
| BNTX | Sell | BIONTECH SEsponsored ads | $3,427,000 | +2.7% | 49,500 | -1.0% | 0.05% | 0.0% |
| RDY | Sell | DR REDDYS LABS LTDadr | $591,000 | -69.9% | 8,500 | -77.0% | 0.01% | -71.4% |
| POL | Exit | POLYONE CORP | $0 | – | -13,600 | -100.0% | -0.01% | – |
| STIM | Exit | NEURONETICS INC | $0 | – | -250,000 | -100.0% | -0.01% | – |
| MTCH | Exit | MATCH GROUP INC | $0 | – | -5,300 | -100.0% | -0.01% | – |
| NARI | Exit | INARI MED INC | $0 | – | -15,000 | -100.0% | -0.01% | – |
| YI | Exit | 111 INCads | $0 | – | -170,525 | -100.0% | -0.02% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -41,000 | -100.0% | -0.02% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -42,500 | -100.0% | -0.02% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -74,400 | -100.0% | -0.04% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -56,800 | -100.0% | -0.04% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -134,261 | -100.0% | -0.08% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -76,900 | -100.0% | -0.13% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.